Product Information
NIFEDIPINE 10 MG CAPSULE is a generic product labeled by Leading Pharma, LLC, priced at $0.2567 per EA under NDC 69315021101. Its NADAC has been published 500 times since Mar 8, 2017.
FDA first approved this application on Oct 8, 1991. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the NIFEdipine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315021101
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NIFEDIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA073250FDA Approved
10/8/1991
TE Code
AB
On Market Since
11/23/2016
Pharmacological Classes
Price Statistics
The NADAC for NIFEDIPINE 10 MG CAPSULE has been published 500 times since Mar 8, 2017, and over the history we have for it it has declined 56.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2567 per EA |
|---|---|
| All-time high | $0.6570 (Jul 12, 2017) |
| All-time low | $0.2212 (Nov 20, 2024) |
| 52-week high | $0.3159 |
| 52-week low | $0.2567 |
| Median price | $0.4132 |
| Average price | $0.4165 |
| Largest weekly change | -36.9% (Nov 20, 2024) |
| Weeks tracked | 500 |
| Tracking since | Mar 8, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the NIFEdipine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
NIFEdipine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NIFEDIPINE 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NIFEDIPINE 10 MG CAPSULE, manufactured by Leading Pharma, LLC, is $0.2567 per EA (NDC 69315021101), effective Sep 30, 2026.
How has the price of NIFEDIPINE 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NIFEDIPINE 10 MG CAPSULE has declined 56.6%. It has been tracked across 500 weekly CMS publications since Mar 8, 2017.
What are the highest and lowest recorded NADAC prices for NIFEDIPINE 10 MG CAPSULE?
Since Mar 8, 2017, the NADAC for NIFEDIPINE 10 MG CAPSULE has ranged from a low of $0.2212 (Nov 20, 2024) to a high of $0.6570 (Jul 12, 2017), with a median of $0.4132 per EA.
Are there cheaper alternatives to NIFEDIPINE 10 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of NIFEDIPINE 10 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NIFEDIPINE 10 MG CAPSULE?
NIFEDIPINE 10 MG CAPSULE (NDC 69315021101) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.